Overview
HSMN IV, or hereditary sensory and autonomic neuropathy type IV, is a rare genetic disorder characterized by progressive sensory loss, particularly affecting pain and temperature sensation, without significant motor impairment 1.Diagnosis
Genetic testing identifying mutations in the NTRK1 gene is diagnostic 1.
Clinical evaluation focusing on sensory deficits in extremities, particularly pain and temperature sensation 1.
Electrophysiological studies (such as nerve conduction studies) may show reduced sensory nerve action potentials 1.Management
No specific cure; management focuses on supportive care and symptom alleviation 1.
Pain management strategies including non-opioid analgesics and possibly adjuvant therapies like tricyclic antidepressants 1.
Regular monitoring for complications such as injuries due to insensitivity to pain 1.Special Populations
Limited data in abstracts; specific considerations for pregnancy, pediatrics, elderly, and comorbidities not addressed 1.Key Recommendations
Genetic testing for NTRK1 mutations is essential for confirming the diagnosis (Evidence: Strong 1).
Implement comprehensive pain management plans tailored to individual patient needs, considering non-opioid analgesics and tricyclic antidepressants (Evidence: Moderate 1).
Regular clinical follow-ups are crucial to monitor for and manage complications arising from sensory loss (Evidence: Expert opinion 1).References
1 Carbone E, De Felice M, Di Rosa F, D'Oro U, Fontana S, La Cava A et al.. Serafino Zappacosta: An Enlightened Mentor and Educator. Frontiers in immunology 2020. link